Zobrazeno 1 - 10
of 76
pro vyhledávání: '"A.G. Wade"'
Publikováno v:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 17(7)
Autor:
B. Hochstrasser, A.G. Wade, F.A. Mahnert, L. Lauritzen, P.M. Isaksen, F. Rouillon, J.C.G. De Swart, R. Nil, Mads J. Andersen, Stine F. Pedersen, H. Koponen
Publikováno v:
British Journal of Psychiatry. 178:304-310
BackgroundMajor depression is highly recurrent. Antidepressant maintenance treatment has proven efficacy against recurrent depression.AimsComparison of prophylactic efficacy of citalopram versus placebo in unipolar, recurrent depression.MethodsPatien
Publikováno v:
Value in Health. 19:A613
Publikováno v:
Annals of the Rheumatic Diseases. 75:583.2-583
Background Epidemiology data on inflammatory back pain (IBP) prevalence within the UK is still lacking. Previous studies from the UK show delay in diagnosis of IBP for up to 8 years. This is partly due to lack of awareness among Public and Primary ca
Publikováno v:
Annals of the Rheumatic Diseases. 75:111.1-111
Background In the management of Spondyloarthropathy, early diagnosis is the key. Previous UK studies show an average delay in diagnosis of IBP of up to 8 years. This is partly due to a failure of individuals with IBP symptoms to present to their GP a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Current medical research and opinion. 23(7)
This study evaluated the efficacy and tolerability of escitalopram and duloxetine in the treatment of major depressive disorder (MDD).Patients were randomised to 24 weeks of double-blind treatment with fixed doses of escitalopram (20 mg) (n = 143) or
Publikováno v:
European Psychiatry. 23:S267-S268
Purpose:To compare the tolerability and efficacy of escitalopram and duloxetine in the treatment of patients with major depressive disorder over 8 weeks.Methods:Data from two randomised, multi-centre, double blind studies in specialist1 or psychiatri
Autor:
A.G. Wade
Publikováno v:
European Neuropsychopharmacology. 17:S137-S138
Publikováno v:
European Psychiatry. 23:S268
Purpose:This study evaluated the efficacy and tolerability of escitalopram and duloxetine in the treatment of major depressive disorder (MDD).Methods:Patients were randomised to 24 weeks of double-blind treatment with fixed doses of escitalopram (20m